Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
about
Accelerated partial breast irradiation: Past, present, and futureCausal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving SurgeryATP directed agent, 8-chloro-adenosine, induces AMP activated protein kinase activity, leading to autophagic cell death in breast cancer cells.The clinicopathological features of second primary cancer in patients with prior breast cancer.Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.Association between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort.Second Primary Cancers After Primary Breast Cancer Diagnosis in Israeli Women, 1992 to 2006.Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapyIncreased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.Breast cancer morbidity: questionnaire survey of patients on the long term effects of disease and adjuvant therapyAccelerated Partial Breast Irradiation (APBI): A review of available techniques.Efficacy of an educational material on second primary cancer screening practice for cancer survivors: a randomized controlled trial.Radiation induced esophageal adenocarcinoma in a woman previously treated for breast cancer and renal cell carcinoma.Mode of primary cancer detection as an indicator of screening practice for second primary cancer in cancer survivors: a nationwide survey in Korea.Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in micePrognostic factors of second primary contralateral breast cancer in early-stage breast cancer.Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registriesUS Insurance Program's Experience With a Multigene Assay for Early-Stage Breast Cancer.Is symptom-oriented follow-up still up to date?Clinical pharmacology of chemotherapy agents in older people with cancerBreast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.Early breast cancer in the older woman.Second malignancies among elderly survivors of cancer.Incidence of acute myeloid leukemia after breast cancer.Second malignancies after multiple myeloma: from 1960s to 2010s.Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study.Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study.Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer.Risk of second cancer after initial treatment of breast cancer: An Osaka Cancer Registry Database study.Oncologists' Experience with Patients with Second Primary Cancer and the Attitudes toward Second Primary Cancer Screening: A Nationwide Survey.The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status.Risk of treatment-related esophageal cancer among breast cancer survivors.Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis.Impact of race and tumor subtype on second malignancy risk in women with breast cancer.Declining second primary ovarian cancer after first primary breast cancer.Endometrial pathology in breast cancer patients: Effect of different treatments on ultrasonographic, hysteroscopic and histological findingsSystemic cancer therapy: achievements and challenges that lie aheadManagement of cancer survivors in clinical and public health perspectives: current status and future challenges in Korea.Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.
P2860
Q28069470-06793513-5E70-48BD-81DA-FF9D2E6A55C0Q28069804-9852D1A3-3F43-498C-B81E-82A7E2676BE2Q33557066-C2820681-E56A-45F2-8F57-4ED62B5FCFD1Q33606244-D8995DFF-A1B9-406C-BCAE-E1F8BF3ECDD0Q33620015-223EA4E8-63F8-4BB0-82E8-9DDBA99464B0Q33733935-36350D67-885F-499E-9FC5-F46FD0471ECCQ33859784-13F6EB97-0949-4E0F-9342-A1AA5445A39AQ33928011-1077D0B0-3B25-476C-9C73-DB88552DCD50Q33938533-510532E5-E79F-4491-A599-8037B79B9106Q34106649-A8967203-4E9A-40AD-94B3-E2150F5C7E09Q34221220-C00221DB-CE69-417A-8A79-58B901F190D8Q34221334-6B4E12AC-8C2A-4F84-A82B-AB92BDF2CE3EQ34371325-6F9AD527-6B8A-410A-B4A1-6097EC5E7925Q34488578-01AE8B80-565C-474F-AE4A-D818639010E4Q34519881-98363FDC-0927-4069-B2B2-CEBCFD013783Q34582515-3A4B7AB5-B847-481E-A0BF-AD32D88F5153Q34914474-729AF933-B1B1-49BA-9ABC-02FB488C774AQ34974208-0A0E3F66-4508-43BA-BF96-1FF753C84279Q35084969-B2704C9D-8A2E-45C7-B7AA-3077CA828772Q35159253-BE2F2AA6-7200-4826-9F5E-7605D0F2B822Q35490056-C5EFC6BD-6247-4F0A-81A3-7B277BB3E4F7Q35584539-7FD07C9F-5C85-4D8F-989B-AB69BF229604Q35599802-F659313F-224C-4AFC-9212-79859F94BD04Q35640784-24607B09-378C-4838-A34D-6F33CD99AABFQ35891594-1FE8FD72-EE28-4CFA-B1B5-80A4EB48A744Q35928283-0789F803-6E10-41B2-AD78-7A369C845E36Q36064817-1913123B-06BE-44BB-A386-B01CD9634830Q36103987-63ED8602-E571-48F5-BFB2-0684D52F3124Q36117185-0AD08AD6-C897-4108-8045-4B136163EFD3Q36126599-FBE46AA3-2718-41C2-908D-5FABCD3E47EBQ36187093-56F3E2EC-8EDB-4E81-91D3-111E303AD63BQ36328710-320EB5AB-FE35-490B-8AF7-2A7D8B3FEDB3Q36408560-8FF03BD4-B4BA-4B07-8812-79C34EAF7106Q36416307-0BDA76B1-5783-41FD-9C77-6E1D10683A78Q36437353-97CCA262-4C0D-4203-A396-C6A224A197AEQ36615095-108C84BB-C16F-46D0-9546-7D3516B75E17Q36774331-E44BD2BE-E6B1-45A7-866D-81CC818CE6A6Q36821958-92AF3D06-A881-40D6-A3E2-8E10FD9D999EQ36841050-A90E2946-D5C3-42D8-B99A-9CFEE801B40FQ37222860-25CB4D91-B009-45A0-9B0B-DE87CEDD951A
P2860
Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Risk of new primary nonbreast ...... Dutch population-based study.
@en
Risk of new primary nonbreast ...... Dutch population-based study.
@nl
type
label
Risk of new primary nonbreast ...... Dutch population-based study.
@en
Risk of new primary nonbreast ...... Dutch population-based study.
@nl
prefLabel
Risk of new primary nonbreast ...... Dutch population-based study.
@en
Risk of new primary nonbreast ...... Dutch population-based study.
@nl
P2093
P50
P356
P1476
Risk of new primary nonbreast ...... a Dutch population-based study
@en
P2093
Flora E van Leeuwen
Jan-Willem W Coebergh
Otto Visser
Pax H B Willemse
Renée Otter
Winette T A van der Graaf
P304
P356
10.1200/JCO.2007.11.9081
P407
P577
2008-03-01T00:00:00Z